Analysts who follow Actinium Pharmaceuticals Inc (ATNM) on average expect it to rise 377.37% over the next twelve months. Those same analysts give the stock an average rating of Hold.
That average rating earns Actinium Pharmaceuticals Inc an Analyst Ranking of 78, which means it ranks higher than 78 of stocks, based on data compiled by InvestorsObserver.
Why are Analyst Ratings Important?
Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve.
InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.
What's Happening With Actinium Pharmaceuticals Inc Stock Today?
Actinium Pharmaceuticals Inc (ATNM) stock is trading at $8.03 as of 11:14 AM on Thursday, Apr 1, a rise of $0.41, or 5.38% from the previous closing price of $7.62. The stock has traded between $7.62 and $8.05 so far today. Volume today is 302,998 compared to average volume of 335,568.
Click Here to get the full report on Actinium Pharmaceuticals Inc (ATNM) Stock.
